Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy
- PMID: 35098366
- DOI: 10.1007/s00277-021-04750-2
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy
Abstract
The impact of splenectomy on health-related quality of life (HRQoL) in patients with immune thrombocytopenia (ITP) remains scarcely explored. Therefore, we evaluated HRQoL with the 36-Item Short-Form Health Survey (SF-36) in an internal cohort of 69 chronic ITP patients, overall and by type of treatment. Of these patients, 26 patients were splenectomized, while other patients were treated medically with thrombopoietin-receptor agonists (TPO-RAs) or immunosuppressive treatment. We also compared HRQoL of the splenectomized patients (internal cohort) with an external cohort of 63 splenectomized ITP patients and the general population. The median follow-up was 10 years (range 1-20). Splenectomized patients had a worse overall HRQoL profile than those who received medical therapy either with TPO-RAs or other treatments (OT), with clinically meaningful differences registered in several domains. These included physical functioning (Δ = - 17.0 and Δ = - 15.2, for TPO-Ras and OT, respectively, p = 0.065), role physical (Δ = - 9.7 and Δ = - 13.8, p = 0.483), and bodily pain (Δ = - 14.2 and Δ = - 18.8, p = 0.053). Compared to the general population, both internal and external splenectomized cohorts had an impaired HRQoL profile. Further studies on HRQoL in splenectomized ITP patients are needed to better understand the long-term impact of this surgical procedure.
Keywords: Health-related quality of life; Immune thrombocytopenia; Splenectomy.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Cooper N, Ghanima W (2019) Immune thrombocytopenia. N Engl J Med 381(10):945–955 - DOI
-
- Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3(22):3780–3817 - DOI
-
- Chaturvedi S, Arnold DM, McCrae KR 2018 Splenectomy for immune thrombocytopenia: down but not out. Blood 15;131(11):1172–82.
-
- Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–4207 - DOI
-
- Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F et al (2016) Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. Am J Hematol 91(10):995–1001 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources